Sponsor of the Day:
Jerkmate
https://reason.com/2025/02/28/pancreatic-cancer-vaccine-shows-potential-in-early-trial/
Pancreatic cancer vaccine shows potential in early trial
Feb 28, 2025 - The five-year survival rate for pancreatic cancer is currently 13 percent, but breakthroughs are bringing hope for successfully treating it.
pancreatic cancer vaccineshows potentialearly trial
https://www.mskcc.org/news/can-mrna-vaccines-fight-pancreatic-cancer-msk-clinical-researchers-are-trying-find-out
Investigational Pancreatic Cancer Vaccine Shows Lasting Results in Early Trial, Supporting...
Apr 20, 2026 - Learn how MSK researchers are deploying mRNA vaccines against pancreatic cancer.
pancreatic cancer vaccineshows lasting resultsearly trialinvestigationalsupporting
https://www.japantimes.co.jp/commentary/2025/03/13/world/cancer-vaccine-shows-hope/
Pancreatic cancer vaccine shows hope. Make the investment. - The Japan Times
Mar 14, 2025 - When researchers offer data suggesting a personalized vaccine might be able to keep the cancer at bay for years, it’s worth paying attention to.
pancreatic cancer vaccinehope makejapan timesshowsinvestment
https://www.nbcnewyork.com/news/national-international/pancreatic-cancer-mrna-vaccine-lasting-results-early-trial/6491932/
Pancreatic cancer mRNA vaccine shows lasting results in early trial – NBC New York
Apr 19, 2026 - Nearly all of the patients who responded to the personalized vaccine are still alive six years later.
vaccine shows lastingnbc new yorkpancreatic cancerearly trialmrna
https://retro.piefed.com/c/medicine/p/22238/pancreatic-cancer-mrna-vaccine-shows-lasting-results-in-an-early-trial
Pancreatic cancer mRNA vaccine shows lasting results in an early trial
vaccine shows lastingpancreatic cancerearly trialmrnaresults